Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing haloperidol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Haloperidol (substance) |
Inferred relationship |
Some |
1 |
Haloperidol measurement |
Component |
True |
Haloperidol (substance) |
Inferred relationship |
Some |
1 |
Accidental haloperidol poisoning |
Causative agent (attribute) |
False |
Haloperidol (substance) |
Inferred relationship |
Some |
|
Intentional haloperidol poisoning |
Causative agent (attribute) |
False |
Haloperidol (substance) |
Inferred relationship |
Some |
|
intoxication par l'halopéridol d'intention indéterminée |
Causative agent (attribute) |
False |
Haloperidol (substance) |
Inferred relationship |
Some |
1 |
Haloperidol adverse reaction |
Causative agent (attribute) |
True |
Haloperidol (substance) |
Inferred relationship |
Some |
1 |
Allergy to haloperidol |
Causative agent (attribute) |
False |
Haloperidol (substance) |
Inferred relationship |
Some |
|
Haloperidol overdose |
Causative agent (attribute) |
True |
Haloperidol (substance) |
Inferred relationship |
Some |
1 |
Accidental haloperidol overdose |
Causative agent (attribute) |
True |
Haloperidol (substance) |
Inferred relationship |
Some |
1 |
Intentional haloperidol overdose |
Causative agent (attribute) |
True |
Haloperidol (substance) |
Inferred relationship |
Some |
1 |
surdose d'halopéridol d'intention indéterminée |
Causative agent (attribute) |
False |
Haloperidol (substance) |
Inferred relationship |
Some |
1 |
Haloperidol [antipsychotic] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Haloperidol (substance) |
Inferred relationship |
Some |
|
Haloperidol 1.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Haloperidol (substance) |
Inferred relationship |
Some |
|
Haloperidol 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Haloperidol (substance) |
Inferred relationship |
Some |
|
Haloperidol 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Haloperidol (substance) |
Inferred relationship |
Some |
|
Haloperidol 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Haloperidol (substance) |
Inferred relationship |
Some |
|
Product containing precisely haloperidol 2 milligram/1 milliliter conventional release oral solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Haloperidol (substance) |
Inferred relationship |
Some |
|
Haloperidol 2mg/5mL s/f oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Haloperidol (substance) |
Inferred relationship |
Some |
|
Haloperidol 1mg/5mL s/f oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Haloperidol (substance) |
Inferred relationship |
Some |
|
Haloperidol 500 microgram oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Haloperidol (substance) |
Inferred relationship |
Some |
|
Haloperidol 1 mg/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Haloperidol (substance) |
Inferred relationship |
Some |
|
halopéridol 10 mg/mL, ampoule de 2 mL de solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Haloperidol (substance) |
Inferred relationship |
Some |
|
Haloperidol 1.5mg/5mL s/f oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Haloperidol (substance) |
Inferred relationship |
Some |
|
décanoate d'halopéridol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Haloperidol (substance) |
Inferred relationship |
Some |
|
Haloperidol [tics, chorea] [see D47..] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Haloperidol (substance) |
Inferred relationship |
Some |
|
Product containing haloperidol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Haloperidol (substance) |
Inferred relationship |
Some |
1 |
Haloperidol-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Haloperidol (substance) |
Inferred relationship |
Some |
1 |
Haloperidol 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Haloperidol (substance) |
Inferred relationship |
Some |
|
Haloperidol decanoate 50mg/mL injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Haloperidol (substance) |
Inferred relationship |
Some |
|
Haloperidol 0.5mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Haloperidol (substance) |
Inferred relationship |
Some |
|
Haloperidol 2 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Haloperidol (substance) |
Inferred relationship |
Some |
|
Haloperidol 100mg injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Haloperidol (substance) |
Inferred relationship |
Some |
|
Haloperidol 5mg injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Haloperidol (substance) |
Inferred relationship |
Some |
|
Oral form haloperidol solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Haloperidol (substance) |
Inferred relationship |
Some |
|
Poisoning by haloperidol |
Causative agent (attribute) |
True |
Haloperidol (substance) |
Inferred relationship |
Some |
1 |
Haloperidol 500 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Haloperidol (substance) |
Inferred relationship |
Some |
|
Haloperidol decanoate (substance) |
Is a |
False |
Haloperidol (substance) |
Inferred relationship |
Some |
|
Haloperidol lactate (substance) |
Is a |
False |
Haloperidol (substance) |
Inferred relationship |
Some |
|
halopéridol 5 mg/1 mL, pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Haloperidol (substance) |
Inferred relationship |
Some |
|
halopéridol 50 mg/1 mL, injection huileuse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Haloperidol (substance) |
Inferred relationship |
Some |
|
halopéridol 100 mg/1 mL, injection huileuse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Haloperidol (substance) |
Inferred relationship |
Some |
|
Intentional haloperidol poisoning |
Causative agent (attribute) |
True |
Haloperidol (substance) |
Inferred relationship |
Some |
1 |
Accidental poisoning by haloperidol |
Causative agent (attribute) |
True |
Haloperidol (substance) |
Inferred relationship |
Some |
1 |
Haloperidol 100mg injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Haloperidol (substance) |
Inferred relationship |
Some |
|
Allergy to haloperidol |
Causative agent (attribute) |
True |
Haloperidol (substance) |
Inferred relationship |
Some |
1 |
Haloperidol 1.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Haloperidol (substance) |
Inferred relationship |
Some |
1 |
Haloperidol 1.5 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Haloperidol (substance) |
Inferred relationship |
Some |
1 |
Haloperidol 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Haloperidol (substance) |
Inferred relationship |
Some |
1 |
Haloperidol 5 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Haloperidol (substance) |
Inferred relationship |
Some |
1 |
Haloperidol 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Haloperidol (substance) |
Inferred relationship |
Some |
1 |
Haloperidol 10 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Haloperidol (substance) |
Inferred relationship |
Some |
1 |
Haloperidol 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Haloperidol (substance) |
Inferred relationship |
Some |
1 |
Haloperidol 20 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Haloperidol (substance) |
Inferred relationship |
Some |
1 |
Haloperidol 500 microgram oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Haloperidol (substance) |
Inferred relationship |
Some |
1 |
Haloperidol 500 microgram oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Haloperidol (substance) |
Inferred relationship |
Some |
1 |
Haloperidol 500 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Haloperidol (substance) |
Inferred relationship |
Some |
1 |
Haloperidol 500 microgram oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Haloperidol (substance) |
Inferred relationship |
Some |
1 |
Haloperidol 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Haloperidol (substance) |
Inferred relationship |
Some |
1 |
Haloperidol 1 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Haloperidol (substance) |
Inferred relationship |
Some |
1 |
Haloperidol 2 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Haloperidol (substance) |
Inferred relationship |
Some |
1 |
Haloperidol 2 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Haloperidol (substance) |
Inferred relationship |
Some |
1 |
Haloperidol decanoate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Haloperidol (substance) |
Inferred relationship |
Some |
|
Haloperidol lactate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Haloperidol (substance) |
Inferred relationship |
Some |
|
Haloperidol 300 microgram/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Haloperidol (substance) |
Inferred relationship |
Some |
|
Haloperidol 200 microgram/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Haloperidol (substance) |
Inferred relationship |
Some |
|
Product containing precisely haloperidol 400 microgram/1 milliliter conventional release oral solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Haloperidol (substance) |
Inferred relationship |
Some |
|
Haloperidol 500 microgram oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Haloperidol (substance) |
Inferred relationship |
Some |
1 |
Haloperidol 500 microgram oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Haloperidol (substance) |
Inferred relationship |
Some |
1 |
Haloperidol 2 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Haloperidol (substance) |
Inferred relationship |
Some |
1 |
Haloperidol 5 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Haloperidol (substance) |
Inferred relationship |
Some |
1 |
Haloperidol 10 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Haloperidol (substance) |
Inferred relationship |
Some |
1 |
Haloperidol 20 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Haloperidol (substance) |
Inferred relationship |
Some |
1 |
Haloperidol 1 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Haloperidol (substance) |
Inferred relationship |
Some |
1 |
Haloperidol 1.5 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Haloperidol (substance) |
Inferred relationship |
Some |
1 |
Haloperidol 1 mg/mL oral solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Haloperidol (substance) |
Inferred relationship |
Some |
1 |
Haloperidol 1 mg/mL oral solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Haloperidol (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely haloperidol 2 milligram/1 milliliter conventional release oral solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Haloperidol (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely haloperidol 2 milligram/1 milliliter conventional release oral solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Haloperidol (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely haloperidol (as haloperidol decanoate) 100 milligram/1 milliliter prolonged-release oil for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Haloperidol (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely haloperidol 20 milligram/2 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Haloperidol (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely haloperidol 20 milligram/2 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Haloperidol (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely haloperidol (as haloperidol decanoate) 50 milligram/1 milliliter prolonged-release oil for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Haloperidol (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely haloperidol 5 milligram/1 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Haloperidol (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely haloperidol 5 milligram/1 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Haloperidol (substance) |
Inferred relationship |
Some |
1 |
Haloperidol only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Haloperidol (substance) |
Inferred relationship |
Some |
1 |
Product containing only haloperidol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Haloperidol (substance) |
Inferred relationship |
Some |
1 |
Haloperidol only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Haloperidol (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely haloperidol 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Haloperidol (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely haloperidol 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Haloperidol (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely haloperidol 5 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Haloperidol (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely haloperidol 5 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Haloperidol (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely haloperidol (as haloperidol decanoate) 50 milligram/1 milliliter prolonged-release oil for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Haloperidol (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely haloperidol (as haloperidol decanoate) 100 milligram/1 milliliter prolonged-release oil for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Haloperidol (substance) |
Inferred relationship |
Some |
1 |
Haloperidol 300 microgram/mL oral solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Haloperidol (substance) |
Inferred relationship |
Some |
1 |
Haloperidol 300 microgram/mL oral solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Haloperidol (substance) |
Inferred relationship |
Some |
1 |
Haloperidol 200 microgram/mL oral solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Haloperidol (substance) |
Inferred relationship |
Some |
1 |
Haloperidol 200 microgram/mL oral solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Haloperidol (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely haloperidol 400 microgram/1 milliliter conventional release oral solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Haloperidol (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely haloperidol 400 microgram/1 milliliter conventional release oral solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Haloperidol (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely haloperidol (as haloperidol decanoate) 100 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Haloperidol (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely haloperidol (as haloperidol decanoate) 50 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Haloperidol (substance) |
Inferred relationship |
Some |
1 |